Comprehensive Analysis of On-Site Molecular Testing for Rotavirus and Enteric Adenoviruses F40/F41
-
By
-
Fatou Kiné Top
-
Cheikh Tidiane Diagne
-
Cheikh Talibouya Touré
-
Julie-Melissa Gonfouli
-
Oumar Faye
-
Yakhya Dieye
-
Julien Reboud
-
Abdourahmane Sow
-
Jonathan M. Cooper
-
Martin Faye
-
March 13, 2026
-
Clinical Scorecard: Comprehensive Analysis of On-Site Molecular Testing for Rotavirus and Enteric Adenoviruses F40/F41
At a Glance
| Category | Detail |
|---|
| Condition | Acute gastroenteritis due to rotavirus and enteric adenoviruses F40/F41 |
| Key Mechanisms | Feco-oral transmission, leading to diarrhea and dehydration |
| Target Population | Children under five years of age, particularly in low-resource settings |
| Care Setting | Clinical and surveillance settings, especially in developing countries |
Key Highlights
- Rotavirus is the leading cause of severe gastroenteritis in infants globally.
- Enteric adenoviruses F40/F41 account for up to 20% of diarrhea episodes worldwide.
- Molecular diagnostics are crucial for accurate detection and management of viral gastroenteritis.
- High prevalence of rotavirus and adenoviruses in low-resource settings complicates timely diagnosis.
- Rapid antigen detection tests are recommended for stool sample analysis.
Guideline-Based Recommendations
Diagnosis
- Utilize rapid molecular assays for detecting rotavirus and enteric adenoviruses in stool samples.
Management
- Implement presumptive treatment based on molecular diagnostics to avoid mismanagement.
Monitoring & Follow-up
- Conduct surveillance for rotavirus and adenovirus infections to inform public health strategies.
Risks
- Inadequate access to laboratory diagnostics may delay outbreak control and patient management.
Patient & Prescribing Data
Children under five years of age with acute gastroenteritis
Focus on rapid diagnosis to guide appropriate treatment and prevent dehydration.
Clinical Best Practices
- Employ point-of-care testing in low-resource settings to enhance diagnostic capabilities.
- Ensure continuous monitoring of rotavirus and adenovirus prevalence in pediatric populations.
References
